Clinical trial
Detection of Genetic Markers of Lung Cancer
NCT00280202 · University of Pittsburgh, Other · Recruiting
Key facts
| NCT number | NCT00280202 |
|---|---|
| Title | Detection of Genetic Markers of Lung Cancer |
| Official title | Detection of Genetic Markers of Lung Cancer Initiation and Progression |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Lung Cancer |
| Intervention type | Procedure |
| Interventions | Biopsy of the major carinal area, Biopsy of abnormal & suspicious areas of the bronchial tree, Evaluation of the tumor for DNA mutations, Bronchoalveolar Lavage (BAL) for cytokine analysis, Correlation of flow cytometric & RT PCR for TNM stage, Analysis of lymph nodes |
| Enrollment | 6,000 |
| Start date | Jun 1, 1996 |
| Primary completion | Dec 1, 2050 |
| Completion | Dec 1, 2050 |
| First posted | Jan 20, 2006 |
| Last update posted | Oct 24, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: